Mikhail Blagosklonny is currently serving as the Professor of Oncology. This is at the Roswell Park Cancer Institute. He is a scientist. His main interests are Aging and Cancer.
Mikhail Blagosklonny has studied at First Pavlov State Medical University which is located in St. Petersburg. This is from where he did his MD in Internal Medicine. He has a Ph.D. too. This is in Experimental Medicine and Cardiology. It is from the same University.
In 2002, Mikhail Blagosklonny became the associate professor of medicine. This was at New York Medical College. It is located in Valhalla, New York.
Later on, Mikhail Blagosklonny moved on to Ordway Research Institute as a senior scientist. In 2009 he joined Roswell Park Cancer Institute. He served here as the Professor of Oncology. He is an excellent professor as he has learned a lot of skills from the various places where he has worked.
Mikhail Blagosklonny is known for his varied research interests. These include Biogerontology which refers to the underlying aging mechanisms besides anti-aging drugs. His research areas also include cancer. He has a special interest in targeted cancer therapies. These help in guarding the healthy cells against damage of any kind.
He is also the editor-in-chief of well-known publications such as Oncotarget along with Cell Cycle. Besides, he is the associate editor of Cancer Biology and Therapy. He is on the editorial board of Cell Death and Differentiation.
There is a hypothesis by Mikhail Blagosklonny that refers to TOR Signaling and talks about its potential role in cancer as well as aging.
Mikhail Blagosklonny has proposed the use of Rapamycin which is used for treating cancer, for life extension. He strongly advocates the use of Rapamycin for doing longevity research.
His research has a varied range. It starts with cellular and molecular biology and includes clinical investigations. Its other aspects are signal transduction, besides ontogenesis, as well as tumor suppressors. He is also looking at the resistance of drugs for selective protection of normal cells besides apoptosis too. His research includes cell cycle, along with anti-cancer therapeutics, along with mitosis.
The aging hyperfunction theory has been authored by Mikhail Blagosklonny. He writes about cell cyclotherapy too along with chemotherapeutic engineering.
He is keenly interested in oncology. He says that aging, as well as cancer, can be controlled. Mikhail Blagosklonny believes that it is possible to cure cancer. This is why he is suggesting using of Rapamycin. In addition, Mikhail Blagosklonny has written more than 300 research articles, besides book chapters, along with reviews. All these have been published under his name. Visit ResearchGate.Net to learn more about Mikhail’s latest work.
Mikhail Blagosklonny is an associate editor for PLOS ONE besides the American Journal of Pathology, as well as the International Journal of Cancer. His hard work, as well as commitment, is evident here. This is why he is among the biggest Oncology researchers of all times today. He has a love for humanity. His vision is that of having a community that is free of all diseases. This is what drives him all the time.